chr19-35831116-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_004646.4(NPHS1):c.3418C>T(p.Arg1140Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000096 in 1,613,828 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1140H) has been classified as Likely benign.
Frequency
Consequence
NM_004646.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NPHS1 | NM_004646.4 | c.3418C>T | p.Arg1140Cys | missense_variant | 27/29 | ENST00000378910.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NPHS1 | ENST00000378910.10 | c.3418C>T | p.Arg1140Cys | missense_variant | 27/29 | 1 | NM_004646.4 | P2 | |
NPHS1 | ENST00000353632.6 | c.3298C>T | p.Arg1100Cys | missense_variant | 26/28 | 5 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152094Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251274Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135842
GnomAD4 exome AF: 0.0000958 AC: 140AN: 1461734Hom.: 0 Cov.: 34 AF XY: 0.0000853 AC XY: 62AN XY: 727182
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152094Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74300
ClinVar
Submissions by phenotype
Finnish congenital nephrotic syndrome Pathogenic:1Uncertain:2
Likely pathogenic, no assertion criteria provided | literature only | Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM) | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Oct 01, 2021 | NM_004646.3(NPHS1):c.3418C>T(R1140C) is a missense variant classified as a variant of uncertain significance in the context of nephrotic syndrome, NPHS1-related. R1140C has been observed in cases with relevant disease (PMID: 26346198, 20172850, 9915943). Functional assessments of this variant are available in the literature (PMID: 24142548, 15496146, 11726550). R1140C has been observed in population frequency databases (gnomAD NFE 0.02%). In summary, there is insufficient evidence to classify NM_004646.3(NPHS1):c.3418C>T(R1140C) as pathogenic or benign. Please note: this variant was assessed in the context of healthy population screening. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 10, 2022 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 31, 2024 | Variant summary: NPHS1 c.3418C>T (p.Arg1140Cys) results in a non-conservative amino acid change in the encoded protein sequence. Three of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0001 in 251274 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in NPHS1 causing Nephrotic Syndrome, Type 1 (0.0001 vs 0.0034), allowing no conclusion about variant significance. c.3418C>T has been reported in the literature in individuals with clinical features of NPHS1-related conditions, however no supportive evidence for causality was provided (e.g. Lenkkeri_1999, Schoeb_2010, Gast_2016). These reports do not provide unequivocal conclusions about association of the variant with Nephrotic Syndrome, Type 1. Publications also reports experimental evidence evaluating an impact on protein function and demonstrated proper cell surface localization for the variant protein (e.g. Liu_2001, Miyai_2014), these data suggest that the variant doesn't substantially affect NPHS1 function, but do not provide unequivocal conclusions about the variant effect. The following publications have been ascertained in the context of this evaluation (PMID: 9915943, 26346198, 20172850, 11726550, 24142548). ClinVar contains an entry for this variant (Variation ID: 56500). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 03, 2022 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 1140 of the NPHS1 protein (p.Arg1140Cys). This variant is present in population databases (rs143092783, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features of NPHS1-related conditions (PMID: 9915943, 26346198). ClinVar contains an entry for this variant (Variation ID: 56500). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change does not substantially affect NPHS1 function (PMID: 11726550, 24142548). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at